Kala Bio (LTS:0JQ2) Accounts Payable : $0.73 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Kala Bio Accounts Payable?

Kala Bio's Accounts Payable for the quarter that ended in Mar. 2024 was $0.73 Mil.

Kala Bio's quarterly Accounts Payable increased from Sep. 2023 ($0.79 Mil) to Dec. 2023 ($0.92 Mil) but then declined from Dec. 2023 ($0.92 Mil) to Mar. 2024 ($0.73 Mil).

Kala Bio's annual Accounts Payable declined from Dec. 2021 ($4.90 Mil) to Dec. 2022 ($2.83 Mil) and declined from Dec. 2022 ($2.83 Mil) to Dec. 2023 ($0.92 Mil).

Kala Bio Accounts Payable Historical Data

The historical data trend for Kala Bio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kala Bio Accounts Payable Chart

Kala Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

2.52

1.72

4.90

2.83

0.92

Kala Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															1.00	0.76	0.79	0.92	0.73

Kala Bio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Kala Bio Accounts Payable Related Terms

Thank you for viewing the detailed overview of Kala Bio's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Kala Bio (LTS:0JQ2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kala Bio Inc (LTS:0JQ2) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

KALA:USA 27F0:Germany

Address

1167 Massachusetts Avenue, Arlington, MA, USA, 02476

Website

https://www.kalarx.com

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing innovative therapies for rare and severe eye diseases. KALA's lead product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Kala Bio (LTS:0JQ2) Headlines

No Headlines